RHYTHM PHARMACEUTICALS, INC. Costs and Expenses in USD from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2019 to Q3 2025.
  • Rhythm Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2025 was $104M, a 34.8% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2025 was $361M, a 4.63% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Costs and Expenses for 2024 was $396M, a 51.1% increase from 2023.
  • Rhythm Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $262M, a 29.1% increase from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $203M, a 17.1% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $361M $104M +$26.8M +34.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 $334M $93.8M +$24.2M +34.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $309M $79.7M -$86.1M -51.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $396M $83.1M +$17.6M +26.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 $378M $77.1M +$10.7M +16.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 $367M $69.6M +$3.73M +5.67% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 $364M $166M +$102M +159% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $262M $65.5M +$14.6M +28.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 $247M $66.5M +$22.9M +52.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $224M $65.8M +$11.7M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $213M $64M +$9.81M +18.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $203M $50.9M -$1.91M -3.62% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 $205M $43.6M -$1.72M -3.79% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $206M $54.2M +$13.5M +33.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $193M $54.2M +$19.8M +57.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $173M $52.8M +$17.7M +50.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $155M $45.3M +$11M +32% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $144M $40.7M +$8.79M +27.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $136M $34.4M -$867K -2.46% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $137M $35.1M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $34.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $31.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $35.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03

RHYTHM PHARMACEUTICALS, INC. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $396M +$134M +51.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $262M +$59M +29.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $203M +$29.6M +17.1% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 $173M +$36.6M +26.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $137M -$9.43M -6.46% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $146M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.